BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1476094)

  • 1. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
    Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
    Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
    Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
    J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
    Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
    Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs.
    Donnay I; Rauïs J; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
    Am J Vet Res; 1995 Sep; 56(9):1188-94. PubMed ID: 7486397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs.
    Sartin EA; Barnes S; Kwapien RP; Wolfe LG
    Am J Vet Res; 1992 Nov; 53(11):2196-200. PubMed ID: 1466519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
    Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
    Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
    Millanta F; Caneschi V; Ressel L; Citi S; Poli A
    J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomopathology of breast cancer and hormone receptors].
    Contesso G; Delarue JC; Mouriesse H; May-Levin F; Garnier H
    Pathol Biol (Paris); 1983 Nov; 31(9):747-54. PubMed ID: 6361672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors in mammary tumours of the cat.
    Rutteman GR; Blankenstein MA; Minke J; Misdorp W
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():32-7. PubMed ID: 1801501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM; Millán Y; Dios R
    Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
    Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
    J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.